Log in to save to my catalogue

Vector-based genetically modified vaccines: Exploiting Jenner’s legacy

Vector-based genetically modified vaccines: Exploiting Jenner’s legacy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7115478

Vector-based genetically modified vaccines: Exploiting Jenner’s legacy

About this item

Full title

Vector-based genetically modified vaccines: Exploiting Jenner’s legacy

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2016-12, Vol.34 (50), p.6436-6448

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Abstract The global vaccine market is diverse while facing a plethora of novel developments. Genetic modification (GM) techniques facilitate the design of ’smarter’ vaccines. For many of the major infectious diseases of humans, like AIDS and malaria, but also for most human neoplastic disorders, still no vaccines are available. It may be speculated...

Alternative Titles

Full title

Vector-based genetically modified vaccines: Exploiting Jenner’s legacy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7115478

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7115478

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2016.06.059

How to access this item